Outcome of adalimumab monotherapy in paediatric non-infectious uveitis.

D A Al-Julandani Narendra Kumar BagriN TsangSarah L N Clarke Ashish Datt UpadhyayC GulyA V Ramanan

Published in: Pediatric rheumatology online journal (2023)

Continuation of adalimumab monotherapy is an effective therapeutic option for the treatment of non-infectious uveitis in children who are intolerant to the combination of adalimumab and methotrexate or mycophenolate mofetil.

Keyphrases

juvenile idiopathic arthritis
combination therapy
rheumatoid arthritis
disease activity
open label
ankylosing spondylitis
intensive care unit
emergency department
young adults
high dose
hidradenitis suppurativa
ulcerative colitis
systemic lupus erythematosus
clinical trial
low dose